Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Global Acute Decompensated Heart Failure Forecast and Market Analysis to 2034: Recent Pipeline Discontinuations and Negative Trial Results Have Limited the Future Growth | ||
By: PR Newswire Association LLC. - 16 Feb 2018 | Back to overview list |
|
DUBLIN, Feb. 16, 2018 /PRNewswire/ -- The "Acute Decompensated Heart Failure Forecast and Market Analysis to 2034" report has been added to ResearchAndMarkets.com's offering. Acute decompensated heart failure (ADHF) is defined as the sudden worsening of heart failure symptoms (mainly edema, dyspnea, and fatigue), which results in severe respiratory distress. ADHF is categorized into hemodynamic stages based on the degree of perfusion and pulmonary capillary wedge pressure. Despite improvements in treatment, ADHF is a burdensome disease associated with high hospitalization and mortality rates in the elderly population.
Key Topics Covered:
Epidemiology: Acute Decompensated Heart Failure
Marketed Drugs: Acute Decompensated Heart Failure
Pipeline: Acute Decompensated Heart Failure
Media Contact: Research and Markets SOURCE Research and Markets |
||
|
||
Copyright 2018 PR Newswire Association LLC. | Back to overview list |